Policy Briefs on THE

ECONOMIC IMPACT OF HIV

Impact of HIV

Brief 12: Trade-offs and Synergies between HIV and Other Health Objectives

By Markus Haacker, Gesine Meyer-Rath

June 2021

Key Points

  • HIV is associated with a range of other diseases, through shared risk factors, effects of HIV on the incidence of other diseases, and the ageing of populations living with HIV. 
  • While investment in HIV may crowd out other health services, investments in the HIV response have contributed to the strengthening of health systems overall. Empirical evidence suggests positive and negative effects on the delivery of specific types of non-HIV health services.

 

  • Integration of HIV and other health services serves to improve efficiency and to address the changing needs of people living with HIV, which – for most patients – has been transformed into a chronic disease.
Download PDF HIV Impact

Technical Briefs

The technical briefs provide more detail on the evidence available on each of the topics.

1. The State of Programme Implementation to Reduce HIV Transmission & Aids-Related Mortality

2. Increased Health and Life Prospects and Their Economic Valuation

3. HIV, Population Dynamics and the Labour Force

4. Human Capital

5. Capital and Investment

6. Productivity and Employment of People Living with HIV

7. Economic Growth – Overview

8. Interactions Between HIV and Poverty

9. Disease Burden Across Population Sub-Groups

10. Trade-offs between Allocation to Health and Other Sectors

11. Domestic Public Funding for HIV

12. Trade-offs and Synergies between HIV and Other Health Objectives

13. Assessing Cost Effectiveness Across HIV and Health Interventions

14. External and Domestic Health Financing, and the Role of Public vs. Private Domestic Health Funding

15. Public and Private Provision of Health and HIV Services

16. Trade-offs within the HIV Budget

17. The Economics of HIV and of HIV Programmes in the Era of Covid-19

Brief 3: HIV, Population Dynamics and the Labour Force

By Markus Haacker, Kate Harris, Gesine Meyer-Rath

21 January 2021

Key Points

  • AIDS-related mortality among working-age adults reduces GDP growth but has an ambiguous effect on GDP per capita.

 

  • In the short run, population size decreases due to reduced fertility and increased child mortality owing to HIV, and GDP per capita increases, but this results in lower growth of the working-age population and of GDP in the long run.

 

  • A smaller elderly cohort due to HIV-related early mortality mitigates the fiscal burden of an ageing population, but as HIV treatment is scaled up, there is higher-than-normal growth of the old population.

 

  • The HIV response reverses most of the demographic impacts and results in higher growth of the working-age population, but reversals in the impact on the population structure play out over decades.
Download PDF HIV Impact

Technical Briefs

The technical briefs provide more detail on the evidence available on each of the topics.

1. The State of Programme Implementation to Reduce HIV Transmission & Aids-Related Mortality

2. Increased Health and Life Prospects and Their Economic Valuation

3. HIV, Population Dynamics and the Labour Force

4. Human Capital

5. Capital and Investment

6. Productivity and Employment of People Living with HIV

7. Economic Growth – Overview

8. Interactions Between HIV and Poverty

9. Disease Burden Across Population Sub-Groups

10. Trade-offs between Allocation to Health and Other Sectors

11. Domestic Public Funding for HIV

12. Trade-offs and Synergies between HIV and Other Health Objectives

13. Assessing Cost Effectiveness Across HIV and Health Interventions

14. External and Domestic Health Financing, and the Role of Public vs. Private Domestic Health Funding

15. Public and Private Provision of Health and HIV Services

16. Trade-offs within the HIV Budget

17. The Economics of HIV and of HIV Programmes in the Era of Covid-19

Wits Health Consortium, University of the Witwatersrand